{
    "2019-05-21": [
        [
            {
                "time": "2019-05-21",
                "original_text": "Validea Peter Lynch Strategy Daily Upgrade Report - 5/21/2019",
                "features": {
                    "keywords": [
                        "Peter Lynch",
                        "Strategy",
                        "Upgrade"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "investing"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-20",
                "original_text": "Here's Why Array BioPharma Is Surging Today",
                "features": {
                    "keywords": [
                        "Array BioPharma",
                        "Surging"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biopharma"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-20",
                "original_text": "These 3 Major Drug Manufacturers Are Strong Performers",
                "features": {
                    "keywords": [
                        "Drug Manufacturers",
                        "Strong Performers"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-20",
                "original_text": "Novartis CEO calls for fixing 'distortions' in health care system ahead of slate of drug launches",
                "features": {
                    "keywords": [
                        "Novartis",
                        "CEO",
                        "health care",
                        "drug launches"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-05-20",
                "original_text": "Novartis CEO says cannabis isn't a focus despite Tilray partnership",
                "features": {
                    "keywords": [
                        "Novartis",
                        "CEO",
                        "cannabis",
                        "Tilray"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "cannabis"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-05-20",
                "original_text": "Cramer Remix: The cannabis stocks I'm eyeing",
                "features": {
                    "keywords": [
                        "Cramer",
                        "cannabis",
                        "stocks"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "cannabis"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-20",
                "original_text": "Fix 'distortions' in health care system ahead of slate of drug launches: Novartis CEO",
                "features": {
                    "keywords": [
                        "health care",
                        "drug launches",
                        "Novartis"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-05-20",
                "original_text": "Novartis CEO on single-payer health care: It is not the right move for America",
                "features": {
                    "keywords": [
                        "Novartis",
                        "CEO",
                        "single-payer",
                        "health care"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}